ID   FTO-2B
AC   CVCL_5124
SY   FTO 2B; FTO2B
DR   BTO; BTO_0003234
DR   Wikidata; Q54835222
RX   PubMed=9745712;
RX   PubMed=9918938;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/f/cell-lines-detail-168.html
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS_0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5123 ! FT-2
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
RX   PubMed=9745712; DOI=10.1111/j.1432-0436.1998.00215.x;
RA   Zvibel I., Fiorino A.S., Brill S., Reid L.M.;
RT   "Phenotypic characterization of rat hepatoma cell lines and
RT   lineage-specific regulation of gene expression by differentiation
RT   agents.";
RL   Differentiation 63:215-223(1998).
//
RX   PubMed=9918938; DOI=10.1002/hep.510290238;
RA   Gong Z.-J., De Meyer S., van Pelt J.F., Hertogs K., Depla E.,
RA   Soumillion A., Fevery J., Yap S.H.;
RT   "Transfection of a rat hepatoma cell line with a construct expressing
RT   human liver annexin V confers susceptibility to hepatitis B virus
RT   infection.";
RL   Hepatology 29:576-584(1999).
//